Faron Pharmaceuticals - Innovative medical solutions (Part 2)

[Koodinikkari]

Health-system burden of higher-risk myelodysplastic syndromes in England: a literature-based micro-cost analysis

https://bmjopen.bmj.com/content/16/8/e119858